{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T09:54:59Z","timestamp":1775210099098,"version":"3.50.1"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Cardiovascular Diseases"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.pcad.2022.10.002","type":"journal-article","created":{"date-parts":[[2022,10,18]],"date-time":"2022-10-18T04:00:14Z","timestamp":1666065614000},"page":"28-37","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Optimal periprocedural antithrombotic treatment in carotid interventions: An international, multispecialty, expert review and position statement"],"prefix":"10.1016","volume":"74","author":[{"given":"Kosmas I.","family":"Paraskevas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Gloviczki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitri P.","family":"Mikhailidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pier Luigi","family":"Antignani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan","family":"Dardik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans-Henning","family":"Eckstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianluca","family":"Faggioli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose","family":"Fernandes e Fernandes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gustav","family":"Fraedrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajay","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arkadiusz","family":"Jawien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mateja K.","family":"Jezovnik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stavros K.","family":"Kakkos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Knoflach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brajesh K.","family":"Lal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaetano","family":"Lanza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christos D.","family":"Liapis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian M.","family":"Loftus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armando","family":"Mansilha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoine","family":"Millon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodolfo","family":"Pini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pavel","family":"Poredos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert M.","family":"Proczka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Baptiste","family":"Ricco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatjana","family":"Rundek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Saba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix","family":"Schlachetzki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauro","family":"Silvestrini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Spinelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Stilo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jasjit S.","family":"Suri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clark J.","family":"Zeebregts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carl J.","family":"Lavie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seemant","family":"Chaturvedi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pcad.2022.10.002_bb0005","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1161\/CIRCRESAHA.121.319947","article-title":"Advances in recurrent stroke prevention: focus on antithrombotic therapies","volume":"130","author":"Mac Grory","year":"2022","journal-title":"Circ Res"},{"key":"10.1016\/j.pcad.2022.10.002_bb0010","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.3390\/biomedicines9121906","article-title":"Antithrombotic therapy in the prevention of stroke","volume":"9","author":"Bir","year":"2021","journal-title":"Biomedicines."},{"key":"10.1016\/j.pcad.2022.10.002_bb0015","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000367988","article-title":"Antithrombotic therapy in carotid artery stenosis: an update","volume":"75","author":"Paciaroni","year":"2015","journal-title":"Eur Neurol"},{"key":"10.1016\/j.pcad.2022.10.002_bb0020","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ejvs.2017.06.021","article-title":"Editor\u2019s choice \u2013 Management of Atherosclerotic Carotid and Vertebral Artery Disease: 2017 clinical practice guidelines of the European Society for Vascular Surgery (ESVS)","volume":"55","author":"Naylor","year":"2018","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.pcad.2022.10.002_bb0025","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/eurheartj\/ehx095","volume":"39","author":"Aboyans","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2022.10.002_bb0030","first-page":"801","article-title":"Diagnosis, treatment and follow-up in extracranial carotid stenosis","volume":"117","author":"Eckstein","year":"2020","journal-title":"Dtsch Arztebl Int"},{"key":"10.1016\/j.pcad.2022.10.002_bb0035","doi-asserted-by":"crossref","first-page":"26S","DOI":"10.1016\/j.jvs.2021.04.074","article-title":"The Society for Vascular Surgery implementation document for the management of extracranial cerebrovascular disease","volume":"75","author":"AbuRahma","year":"2022","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.pcad.2022.10.002_bb0040","doi-asserted-by":"crossref","first-page":"e364","DOI":"10.1161\/STR.0000000000000375","article-title":"2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association\/ American Stroke Association","volume":"52","author":"Kleindorfer","year":"2021","journal-title":"Stroke."},{"key":"10.1016\/j.pcad.2022.10.002_bb0045","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1136\/bmj.296.6618.313","article-title":"Randomised trial of prophylactic daily aspirin in British male doctors","volume":"296","author":"Peto","year":"1988","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.pcad.2022.10.002_bb0050","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJM198907203210301","article-title":"Final report on the aspirin component of the ongoing Physicians\u2019 health study","volume":"321","author":"Steering Committee of the Physicians\u2019\u2019 Health Study Research Group","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2022.10.002_bb0055","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1001\/jama.1992.03490100090033","article-title":"Aspirin effects on mortality and morbidity in patients with diabetes mellitus. Early Treatment Diabetic Retinopathy Study report 14","volume":"268","author":"ETDRS Investigators","year":"1992","journal-title":"JAMA."},{"key":"10.1016\/j.pcad.2022.10.002_bb0060","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/S0140-6736(98)04311-6","article-title":"Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group","volume":"351","author":"Hansson","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.pcad.2022.10.002_bb0065","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0140-6736(00)03539-X","article-title":"Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Collaborative Group of the Primary Prevention Project","volume":"357","author":"de Gaetano","year":"2001","journal-title":"Lancet."},{"key":"10.1016\/j.pcad.2022.10.002_bb0070","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1056\/NEJMoa050613","article-title":"A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women","volume":"352","author":"Ridker","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2022.10.002_bb0075","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.a1840","article-title":"The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease","volume":"337","author":"Belch","year":"2008","journal-title":"BMJ."},{"key":"10.1016\/j.pcad.2022.10.002_bb0080","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1001\/jama.2010.221","article-title":"Aspirin for asymptomatic atherosclerosis trialists. Aspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index: a randomized controlled trial","volume":"303","author":"Fowkes","year":"2010","journal-title":"JAMA."},{"key":"10.1016\/j.pcad.2022.10.002_bb0085","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1001\/jama.2014.15690","article-title":"Low-dose aspirin for primary prevention of cardiovascular events in Japanese patients 60 years or older with atherosclerotic risk factors: a randomized clinical trial","volume":"312","author":"Ikeda","year":"2014","journal-title":"JAMA."},{"key":"10.1016\/j.pcad.2022.10.002_bb0090","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1161\/CIRCULATIONAHA.116.025760","article-title":"Low-dose aspirin for primary prevention of cardiovascular events in patients with Type 2 diabetes mellitus: 10-year follow-up of a randomized controlled trial","volume":"135","author":"Saito","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2022.10.002_bb0095","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/S0140-6736(18)31924-X","article-title":"Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial","volume":"392","author":"Gaziano","year":"2018","journal-title":"Lancet."},{"key":"10.1016\/j.pcad.2022.10.002_bb0100","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1056\/NEJMoa1804988","article-title":"Effects of aspirin for primary prevention in persons with diabetes mellitus","volume":"379","author":"Bowman","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2022.10.002_bb0105","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1056\/NEJMoa1803955","article-title":"Effect of aspirin on all-cause mortality in the healthy elderly","volume":"379","author":"McNeil","year":"2018","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.pcad.2022.10.002_bb0110","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s10557-018-6802-1","article-title":"Aspirin for primary prevention of cardiovascular disease and renal disease progression in chronic kidney disease patients: a multicenter randomized clinical trial (AASER study)","volume":"32","author":"Goicoechea","year":"2018","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.pcad.2022.10.002_bb0115","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1016\/j.jacc.2019.03.501","article-title":"Aspirin for primary prevention of cardiovascular events","volume":"73","author":"Abdelaziz","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2022.10.002_bb0120","doi-asserted-by":"crossref","first-page":"836","DOI":"10.7326\/M16-0577","article-title":"Aspirin use for the primary prevention of cardiovascular disease and colorectal cancer: U.S. preventive services task force recommendation statement","volume":"164","author":"Bibbins-Domingo","year":"2016","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.pcad.2022.10.002_bb0125","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.ejvs.2015.06.115","article-title":"Long-term mortality in patients with asymptomatic carotid stenosis: implications for statin therapy","volume":"50","author":"Giannopoulos","year":"2015","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.pcad.2022.10.002_bb0130","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(09)60503-1","article-title":"Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials","volume":"373","author":"Baigent","year":"2009","journal-title":"Lancet."},{"key":"10.1016\/j.pcad.2022.10.002_bb0135","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1016\/S0140-6736(99)05388-X","article-title":"Low-dose and high-dose acetylsalicylic acid for patients undergoing carotid endarterectomy: a randomised controlled trial. ASA and Carotid Endarterectomy (ACE) Trial Collaborators","volume":"353","author":"Taylor","year":"1999","journal-title":"Lancet."},{"key":"10.1016\/j.pcad.2022.10.002_bb0140","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1747-4949.2012.00790.x","article-title":"Risk of recurrent stroke before carotid endarterectomy: the ANSYSCAP study","volume":"8","author":"Johansson","year":"2013","journal-title":"Int J Stroke"},{"key":"10.1016\/j.pcad.2022.10.002_bb0145","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1161\/STROKEAHA.109.548032","article-title":"High risk of early neurological recurrence in symptomatic carotid stenosis","volume":"40","author":"Ois","year":"2009","journal-title":"Stroke."},{"key":"10.1016\/j.pcad.2022.10.002_bb0150","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.3171\/2013.7.JNS122128","article-title":"Risk of very early recurrent cerebrovascular events in symptomatic carotid artery stenosis","volume":"119","author":"Mono","year":"2013","journal-title":"J Neurosurg"},{"key":"10.1016\/j.pcad.2022.10.002_bb0155","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee","volume":"348","author":"CAPRIE Steering Committee","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.pcad.2022.10.002_bb0160","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1215340","article-title":"Clopidogrel with aspirin in acute minor stroke or transient ischemic attack","volume":"369","author":"Wang","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2022.10.002_bb0165","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1056\/NEJMoa1800410","article-title":"Clinical research collaboration, neurological emergencies treatment trials network, and the POINT Investigators. Clopidogrel and aspirin in acute ischemic stroke and high-risk TIA","volume":"379","author":"Johnston","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2022.10.002_bb0170","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1161\/CIRCULATIONAHA.119.040713","article-title":"Time course for benefit and risk of clopidogrel and aspirin after acute transient ischemic attack and minor ischemic stroke","volume":"140","author":"Johnston","year":"2019","journal-title":"Circulation."},{"key":"10.1016\/j.pcad.2022.10.002_bb0175","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1001\/jamaneurol.2019.2531","volume":"76","author":"Pan","year":"2019","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.pcad.2022.10.002_bb0180","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S1474-4422(07)70250-8","article-title":"Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): a randomised controlled pilot trial","volume":"6","author":"Kennedy","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.pcad.2022.10.002_bb0185","article-title":"Clopidogrel plus aspirin versus aspirin alone for acute minor ischaemic stroke or high risk transient ischaemic attack: systematic review and meta-analysis","volume":"363","author":"Hao","year":"2018","journal-title":"BMJ."},{"key":"10.1016\/j.pcad.2022.10.002_bb0190","article-title":"Dual antiplatelet therapy with aspirin and clopidogrel for acute high risk transient ischaemic attack and minor ischaemic stroke: a clinical practice guideline","volume":"363","author":"Prasad","year":"2018","journal-title":"BMJ."},{"key":"10.1016\/j.pcad.2022.10.002_bb0195","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jns.2017.03.010","article-title":"High on treatment platelet reactivity to aspirin and clopidogrel in ischemic stroke: a systematic review and meta-analysis","volume":"376","author":"Fiolaki","year":"2017","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.pcad.2022.10.002_bb0200","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1001\/jama.2016.8662","article-title":"Association between CYP2C19 loss-of-function allele status and efficacy of clopidogrel for risk reduction among patients with minor stroke or transient ischemic attack","volume":"316","author":"Wang","year":"2016","journal-title":"JAMA."},{"key":"10.1016\/j.pcad.2022.10.002_bb0205","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1159\/000515829","article-title":"Stroke prevention: little-known and neglected aspects","volume":"50","author":"Azarpazhooh","year":"2021","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.pcad.2022.10.002_bb0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-510X(96)00308-5","article-title":"European stroke prevention study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke","volume":"143","author":"Diener","year":"1996","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.pcad.2022.10.002_bb0215","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/S0140-6736(06)68734-5","article-title":"Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial","volume":"367","author":"ESPRIT Study Group","year":"2006","journal-title":"Lancet."},{"key":"10.1016\/j.pcad.2022.10.002_bb0220","article-title":"Aspirin plus dipyridamole has the highest surface under the cumulative ranking curves (SUCRA) values in terms of mortality, intracranial hemorrhage, and adverse event rate among 7 drug therapies in the treatment of cerebral infarction","volume":"97","author":"Zhang","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.pcad.2022.10.002_bb0225","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1161\/hs1101.098524","article-title":"Risk factors, outcome, and treatment in subtypes of ischemic stroke: the German stroke data bank","volume":"32","author":"Grau","year":"2001","journal-title":"Stroke."},{"key":"10.1016\/j.pcad.2022.10.002_bb0230","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/clc.22846","article-title":"Efficacy and safety of rivaroxaban compared with warfarin in patients with carotid artery disease and nonvalvular atrial fibrillation: insights from the ROCKET AF trial","volume":"41","author":"Kochar","year":"2018","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.pcad.2022.10.002_bb0235","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.ejvs.2021.12.037","article-title":"Editor\u2019s choice - peri-operative outcomes of carotid endarterectomy are not improved on dual antiplatelet therapy vs. aspirin monotherapy: a systematic review and Meta-analysis","volume":"63","author":"Ku","year":"2022","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.pcad.2022.10.002_bb0240","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.ejvs.2015.07.019","article-title":"Dual antiplatelet therapy prior to expedited carotid surgery reduces recurrent events prior to surgery without significantly increasing peri-operative bleeding complications","volume":"50","author":"Batchelder","year":"2015","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.pcad.2022.10.002_bb0245","doi-asserted-by":"crossref","first-page":"288","DOI":"10.3349\/ymj.2013.54.2.288","article-title":"The influence of anti-platelet resistance on the development of cerebral ischemic lesion after carotid artery stenting","volume":"54","author":"Song","year":"2013","journal-title":"Yonsei Med J"},{"issue":"5","key":"10.1016\/j.pcad.2022.10.002_bb0250","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1136\/neurintsurg-2013-010771","article-title":"Carotid artery stenting outcomes: do they correlate with antiplatelet response assays?","volume":"6","author":"Sorkin","year":"2014","journal-title":"J Neurointerv Surg"},{"key":"10.1016\/j.pcad.2022.10.002_bb0255","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.21037\/atm-20-7153","article-title":"Clinical importance of testing for clopidogrel resistance in patients undergoing carotid artery stenting-a systematic review","volume":"9","author":"Collette","year":"2021","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.pcad.2022.10.002_bb0260","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jvs.2020.04.518","article-title":"Outcomes and strategy of tailored antiplatelet therapy with ticagrelor in patients undergoing transcarotid artery revascularization","volume":"73","author":"Ghamraoui","year":"2021","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.pcad.2022.10.002_bb0265","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.jvs.2021.09.045","article-title":"Efficacy and safety of perioperative dual antiplatelet therapy with ticagrelor versus clopidogrel in carotid artery stenting","volume":"75","author":"Marcaccio","year":"2022","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.pcad.2022.10.002_bb0270","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1016\/j.jvs.2021.11.060","article-title":"Clopidogrel versus ticagrelor for antiplatelet therapy in transcarotid artery revascularization (TCAR) in the Society for Vascular Surgery Vascular Quality Initiative","volume":"75","author":"Ghamraoui","year":"2022","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.pcad.2022.10.002_bb0275","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1177\/1074248420931624","article-title":"Carotid stent restenosis and thrombosis in rabbits: the effect of antiplatelet agents","volume":"25","author":"Kadoglou","year":"2020","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10.1016\/j.pcad.2022.10.002_bb0280","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1001\/jamasurg.2019.2952","article-title":"Carotid endarterectomy and carotid artery stenting for patients with crescendo transient ischemic attacks: a systematic review","volume":"154","author":"Fereydooni","year":"2019","journal-title":"JAMA Surg"},{"key":"10.1016\/j.pcad.2022.10.002_bb0285","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.jvs.2017.10.085","article-title":"Patient characteristics and in-hospital outcomes of emergency carotid endarterectomy and carotid stenting after stroke in evolution","volume":"68","author":"Knappich","year":"2018","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.pcad.2022.10.002_bb0290","doi-asserted-by":"crossref","first-page":"e564","DOI":"10.1161\/STROKEAHA.109.558528","article-title":"Systematic review of the operative risks of carotid endarterectomy for recently symptomatic stenosis in relation to the timing of surgery","volume":"40","author":"Rerkasem","year":"2009","journal-title":"Stroke."},{"key":"10.1016\/j.pcad.2022.10.002_bb0295","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1001\/archneurol.2012.1633","article-title":"Low-molecular-weight heparin and early neurologic deterioration in acute stroke caused by large artery occlusive disease","volume":"69","author":"Wang","year":"2012","journal-title":"Arch Neurol"},{"key":"10.1016\/j.pcad.2022.10.002_bb0300","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0140-6736(16)30468-8","article-title":"Effects of aspirin on risk and severity of early recurrent stroke after transient ischaemic attack and ischaemic stroke: time-course analysis of randomised trials","volume":"388","author":"Rothwell","year":"2016","journal-title":"Lancet."},{"key":"10.1016\/j.pcad.2022.10.002_bb0305","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jvs.2018.11.029","article-title":"In-hospital outcomes of transcarotid artery revascularization and carotid endarterectomy in the Society for Vascular Surgery Vascular Quality Initiative","volume":"71","author":"Schermerhorn","year":"2020","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.pcad.2022.10.002_bb0310","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/j.jvs.2021.05.028","article-title":"Transcarotid artery revascularization versus carotid endarterectomy and transfemoral stenting in octogenarians","volume":"74","author":"Mehta","year":"2021","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.pcad.2022.10.002_bb0315","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jvs.2021.07.242","article-title":"Propensity score-matched analysis of 1-year outcomes of transcarotid revascularization with dynamic flow reversal, carotid endarterectomy, and transfemoral carotid artery stenting","volume":"75","author":"Malas","year":"2022","journal-title":"J Vasc Surg"}],"container-title":["Progress in Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062022001013?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062022001013?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T00:21:08Z","timestamp":1758500468000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033062022001013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":63,"alternative-id":["S0033062022001013"],"URL":"https:\/\/doi.org\/10.1016\/j.pcad.2022.10.002","relation":{},"ISSN":["0033-0620"],"issn-type":[{"value":"0033-0620","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimal periprocedural antithrombotic treatment in carotid interventions: An international, multispecialty, expert review and position statement","name":"articletitle","label":"Article Title"},{"value":"Progress in Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcad.2022.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}